Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT

Fate Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-34.07M -37.62M -52.15M -47.68M -38.43M -48M -44.12M -45.17M -52.76M -18.88M -56.36M -83.56M -76.11M -65.69M -68.62M -43.31M -55.13M -45.09M
Depreciation & Amortization
2.43M 3.33M 4.81M -2.94M 4.72M 4.82M 4.88M 4.74M 4.47M 4.19M 4.84M 3.19M 2.96M 2.76M 2.21M 1.52M 1.17M 959K
Stock-Based Compensation
7.15M 7.38M 9.12M 11.77M 9.63M 10.98M 9.47M 10.1M 12.9M 10.98M 19.39M 19.47M 20.54M 19.33M 14.59M 13.54M 13.25M 12.98M
Other Working Capital
-1.42M 3.32M -3.15M 3.74M -3.92M 4.15M 8.65M -4.12M 3.37M 7.57M -17.96M 7.22M -235K -5.95M 11K 6.28M 2.9M 1.93M
Other Non-Cash Items
-175K -1.53M 12.33M 6.31M -4.44M -1.76M -12.88M -1.87M -4.2M -37.3M -10.71M -4.27M 78K -9.89M -6.68M -15.77M 7.58M -3.23M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 6.2M -3.26M -2.94M n/a n/a n/a n/a n/a 1.07M 1.37M 1.49M 1.14M
Change in Working Capital
73K -5.37M -1.91M 3.13M -3.79M 614K -189K -2.82M 14.04M 12.15M -32.55M 10.12M -1.16M -11.13M -12.87M 9.28M -460K 6.15M
Operating Cash Flow
-24.59M -33.81M -27.8M -29.42M -32.31M -33.35M -36.64M -38.27M -28.49M -28.86M -75.39M -55.05M -53.16M -64.61M -70.29M -33.38M -32.11M -27.1M
Capital Expenditures
-1.36M -1.2M -98K -495K -51K -86K -181K -565K -2.2M -3.21M -6.68M -8.68M -10.13M -10.08M -18.37M -14.73M -13.62M -3.98M
Cash Acquisitions
122K n/a n/a n/a n/a n/a 73.28M -25.37M -35.37M -12.55M -59.79M -89.05M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-50.81M -48.62M -38.01M -64.74M -128.67M -86.33M -49.97M -102.13M -92.26M -114.45M -107.1M -101.58M -63.95M -132.17M -173.45M -165.47M -99.34M -529.91M
Sales Maturities Of Investments
71.64M 92.49M 60.92M 90.7M 75.34M 103.73M 95.5M 127.5M 127.63M 127M 166.89M 190.63M 114.36M 135.22M 263.09M 258.16M 111.58M 62M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -73.28M 25.37M 35.37M 12.55M 59.79M 89.05M 50.42M 3.06M 89.65M 92.69M 12.25M -467.91M
Investing Cash Flow
19.59M 42.67M 22.82M 25.46M -53.37M 17.31M 45.35M 24.8M 33.17M 9.34M 53.11M 80.38M 40.29M -7.03M 71.28M 77.96M -1.37M -471.89M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -666K 666K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -12.74M n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.32M n/a 77.66M n/a 1.94M 20.3M n/a n/a 58K 207K 1.52M 1.49M 3.41M 2.8M 3.42M 20.68M 3.72M 5.61M
Financial Cash Flow
1.32M n/a 3.13M n/a 1.27M 95.49M -180K n/a 58K 207K 1.52M 1.49M 3.41M 2.8M 3.42M 7.94M 3.72M 438.05M
Net Cash Flow
-3.67M 8.86M -1.85M -3.96M -84.41M 79.45M 8.54M -13.47M 4.73M -19.31M -20.76M 26.82M -9.47M -68.84M 4.4M 52.53M -29.76M -60.93M
Free Cash Flow
-25.95M -35.01M -27.9M -29.91M -32.36M -33.44M -36.82M -38.84M -30.69M -32.07M -82.07M -63.72M -63.29M -74.7M -88.66M -48.11M -45.73M -31.08M